Scientific guidelines with SmPC recommendations
Scientific guidelines with SmPC recommendations EMA/813125/2012 Page 3/5 . Guidelines Reference to specific SmPC section(s) Evaluation of the pharmacokinetics of medicinal products in
Download Scientific guidelines with SmPC recommendations
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
PRODUCT MONOGRAPH FLECAINIDE - AA Pharma
www.aapharma.caPRODUCT MONOGRAPH FLECAINIDE Flecainide Acetate Tablets USP 50 mg and 100 mg ANTIARRHYTHMIC AGENT AA PHARMA INC. DATE OF REVISION: 1165 …
Design and analysis of thorough QT studies - Biopharmnet
www.biopharmnet.comDesign and Analysis of Thorough QT Studies.
BATCH Q: Quality - International Council for Harmonisation ...
www.ich.orgGUIDELINE INDEX BATCH Q: Quality Finalised Guidelines (Step 4) Q1A(R2) Stability Testing of New Drug Substances and Products (Second Revision) Feb. 2003
TAMBOCORTM Injection - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET TAMBOCORTM Injection TAMBOCOR Page 1 of 15 1 PRODUCT NAME TAMBOCOR 10 mg/mL injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ampoule contains flecainide acetate 150 mg in acetate buffered Water for Injections BP 15 mL.
Amiodarone Hydrochloride 150 mg/3 mL Name of the …
www.medsafe.govt.nz2 Amiodarone Hydrochloride 150 mg/3 mL 01102015 Pharmacology Actions Amiodarone is a Class III antiarrhythmic agent prolonging the action potential duration and
Electrocardiographic Changes in Infectious Diseases
www.turner-white.comwww.turner-white.com Hospital Physician September 2007 15 E lectrocardiography is a valuable, noninvasive graphical representation of the heart’s electri-cal activity.